申请人:Pfizer Limited
公开号:US20140315933A1
公开(公告)日:2014-10-23
The present invention relates to new sulfonamide URAT-1 inhibitor compounds of formula (I) or pharmaceutically acceptable salts thereof:
to compositions containing them, to processes for their preparation and to intermediates used in such processes and to methods of treatment; wherein R
1
, R
2
, R
3
, R
4
, R
5
and R
6
are as defined in the description.
本发明涉及新的磺胺类URAT-1抑制剂化合物,化学式为(I)或其药用可接受的盐:包含它们的组合物,其制备方法,用于这些方法的中间体以及治疗方法;其中R1、R2、R3、R4、R5和R6如描述中所定义。